New platform integrates advanced cardiac mapping and ablation workflow, offering a novel treatment option for AFib patients at risk of stroke and heart failure
The trial aims to measure AF burden—the percentage of time patients spend in arrhythmia—as its primary efficacy endpoint
Private financing round supported by Fidelity Management & Research Company, T. Rowe Price and Durable Capital Partners
As an initial remote monitoring diagnostic approach, Philips BioTel Heart MCOT detected 4.6 times more patients with atrial fibrillation compared to implantable loop recorder alone
New-generation cardiac ablation technology expands treatment options for atrial fibrillation patients, offering a non-thermal approach to improve safety and procedural efficiency
The approval was granted by Agenzia Italiana del Farmaco
Offers a non-surgical treatment option for tricuspid regurgitation, a commonly underdiagnosed heart valve disorder linked to heart failure
The company has supported the initiative since its inception, contributing to screening efforts in around 120 countries
The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
Subscribe To Our Newsletter & Stay Updated
